Boston An independent LDT provider
NOTE:Immunovia has ceased commercialization of the IMMray PanCan-d test. More information available here: https://rb.gy/09bxx

Listing transfer (2018)

Prospectus for Immunovia AB in connection with the change of listing venue to Nasdaq Stockholm.

Prospectus Immunovia AB 2018 (PDF in Swedish)

Link to Immunovia’s Financial Reports.

Home Prospectuses Listing transfer (2018)